Get started
Author

Laura Medri

Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy
2015 · Paola Ulivi, Elisa Chiadini, et al. · Clinical Lung Cancer · 91
c-kit and SCF Expression in Normal and Tumor Breast Tissue
2004 · Paola Ulivi, Wainer Zoli, et al. · Breast Cancer Research and Treatment · 69
Multicentric/multifocal breast cancer with a single histotype: is the biological characterization of all individual foci justified?
2012 · F. Buggi, S. Folli, et al. · Annals of Oncology · 68
PDF
Hormonal Receptor, Human Epidermal Growth Factor Receptor-2, and Ki67 Discordance between Primary Breast Cancer and Paired Metastases: Clinical Impact
2012 · Toni Ibrahim, Alberto Farolfi, et al. · Oncology · 62
Prognostic Relevance of Mitotic Activity in Patients with Node-Negative Breast Cancer
2003 · Laura Medri, Annalisa Volpi, et al. · Modern Pathology · 59
PDF
Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?
2003 · Anna Maria Granato, Oriana Nanni, et al. · Breast Cancer Research · 57
PDF
Vascular endothelial growth factor and prognosis in patients with node‐negative breast cancer
2001 · Franca De Paola, Anna Maria Granato, et al. · International Journal of Cancer · 50
Urine Telomerase: An Important Marker in the Diagnosis of Bladder Cancer
2004 · Maria Aurora Sanchini, Sara Bravaccini, et al. · Neoplasia · 43
PDF
In vitro irradiation system for radiobiological experiments
2013 · Anna Tesei, Anna Sarnelli, et al. · Radiation Oncology · 40
PDF
Tumor microvessel density and prognosis in node-negative breast cancer
2000 · Laura Medri, Oriana Nanni, et al. · International Journal of Cancer · 38
Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations
2014 · D. Amadori, P. Serra, et al. · Breast Cancer Research and Treatment · 34
Efficacy of a nitric oxide–releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell linesin vitroand xenografts
2006 · Carlo Leonetti, Marco Scarsella, et al. · Molecular Cancer Therapeutics · 34
PDF
Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2
2003 · F De Paola, R Ridolfi, et al. · British Journal of Cancer · 33
PDF
Albumin nanocapsules containing fenretinide: pre-clinical evaluation of cytotoxic activity in experimental models of human non-small cell lung cancer
2014 · Sara Pignatta, Isabella Orienti, et al. · Nanomedicine Nanotechnology Biology and Medicine · 30
Potential of telomerase expression and activity in cervical specimens as a diagnostic tool
2005 · S Bravaccini, M A Sanchini, et al. · Journal of Clinical Pathology · 30
Quality Control for Biomarker Determination in Oncology: The Experience of the Italian Network for Quality Assessment of Tumor Biomarkers (INQAT)
2002 · A. Paradiso, S. Volpe, et al. · The International Journal of Biological Markers · 30
PDF
Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma
2016 · Alessandro De Vita, Giacomo Miserocchi, et al. · Molecules · 26
PDF
Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients
1998 · R. Ridolfi, Emanuela Flamini, et al. · Cancer Immunology Immunotherapy · 25
Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines
2007 · Anna Tesei, Marco Rosetti, et al. · Journal of Translational Medicine · 23
PDF
Benefit from anthracyclines in relation to biological profiles in early breast cancer
2013 · Andrea Rocca, Sara Bravaccini, et al. · Breast Cancer Research and Treatment · 21
Comparison between differentcell kinetic variables in human breast cancer
2000 · F. Barzanti, M. Dal Susino, et al. · Cell Proliferation · 19
PDF
NCX 4016, a nitric oxide-releasing aspirin derivative, exhibits a significant antiproliferative effect and alters cell cycle progression in human colon adenocarcinoma cell lines
2003 · Anna Tesei, Luca Ricotti, et al. · International Journal of Oncology · 18
Interobserver Reproducibility of Immunohistochemical Her-2/Neu Assessment in Human Breast Cancer: An Update from INQAT round III
2005 · Italian Network for Quality Assurance of Tumor Biomarkers (INQAT) Group, A. Paradiso, et al. · The International Journal of Biological Markers · 17
Usefulness of Immunological Detection of the Human Telomerase Reverse Transcriptase
2005 · Annalisa Volpi, Sara Bravaccini, et al. · Analytical Cellular Pathology · 16
Efficacy of Different Sequences of Radio‐ and Chemotherapy in Experimental Models of Human Melanoma
2014 · Chiara Arienti, Wainer Zoli, et al. · Journal of Cellular Physiology · 12
Works count: 58
Citation count: 1,031
H-index: 20
I10-index: 29
Year
Topic
Type